Citius Oncology, Inc.
CTOR
$0.70
$0.022.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7,295,400.00% | 3,924,800.00% | -- | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 57.42% | 169.53% | -- | -- | -- |
| Prepaid Expenses | 17.14% | -50.69% | -89.01% | -69.69% | -65.09% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 117.47% | 151.10% | 82.97% | 102.54% | 120.84% |
|
|
|||||
| Total Current Assets | 117.47% | 151.10% | 82.97% | 102.54% | 120.84% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.78% | 0.00% | 83.50% | 83.50% | 83.50% |
| Total Assets | 21.54% | 19.64% | 83.39% | 86.97% | 89.55% |
|
|
|||||
| Total Accounts Payable | 77.83% | 256.58% | -- | 1,423.38% | 2,765.66% |
| Total Accrued Expenses | 75.49% | 2,210.95% | -49.28% | -49.61% | -61.18% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -35.74% | -20.25% | -- | -- | -- |
| Total Other Current Liabilities | -35.74% | -20.25% | -- | -- | -- |
| Total Current Liabilities | 3.02% | 51.35% | 68.80% | 80.09% | 83.02% |
|
|
|||||
| Total Current Liabilities | 3.02% | 51.35% | 68.80% | 80.09% | 83.02% |
| Long-Term Debt | 0.00% | 0.00% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 53.06% | 61.17% | 59.14% | 56.70% | 53.72% |
| Total Liabilities | 4.81% | 46.69% | 79.86% | 92.00% | 96.69% |
|
|
|||||
| Common Stock & APIC | 46.73% | 27.50% | 84.74% | 87.88% | 91.36% |
| Retained Earnings | -51.45% | -63.04% | -81.86% | -93.82% | -100.98% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 41.47% | -2.76% | 90.23% | 79.59% | 81.69% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 41.47% | -2.76% | 90.23% | 79.59% | 81.69% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 41.47% | -2.76% | 90.23% | 79.59% | 81.69% |
|
|
|||||